-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$9.50452.33% Upside
ESSA Pharma Inc. Frequently Asked Questions
-
What analysts cover ESSA Pharma Inc.?
ESSA Pharma Inc. has been rated by research analysts at Piper Sandler, Oppenheimer in the past 90 days.